PURE Biosciences Inc. Stock Analysis PURE
PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. The company is headquartered in El Cajon, California and currently employs 11 full-time employees. The firm is focused on developing and commercializing its proprietary antimicrobial products, primarily in the food and beverage industry. The company provides solutions to combat the health and environmental challenges of pathogens and hygienic control. Its technology platform is based on patented, stabilized ionic silver, and its initial products contain SDC. Its registered offerings include PURE Hard Surface, a food contact surface sanitizer and disinfectant designed for restaurant chains, food processors, and transportation companies, as well as PURE Control, a direct food contact processing aid. The company also supplies SDC-based formulations as raw material ingredients for personal care products. Its SDC-based disinfecting and sanitizing products are registered with the United States Environmental Protection Agency, the United States Food and Drug Administration, and Health Canada.
Read More PURE Biosciences Inc (PURE) Chart
Key Statistics of PURE Biosciences Inc (PURE)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.07Volume
10.47KP/E Ratio (TTM)
-52 Week Range
Market Cap
7.50MAvg. Volume
29.27KDividend Yield
-Financial Metrics & Statements of PURE Biosciences Inc (PURE)
FAQ's for PURE Biosciences Inc (PURE)
- According to Musaffa’s Shariah screening methodology, PURE Biosciences Inc (PURE) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.